schizophrenia

Biotech

Karuna CEO says biotech can launch drugs too, amid deal rumors

Karuna is 24 months out from a major drug launch and the industry is buzzing with rumors that the biotech will seek a deal for commercialization.
Annalee Armstrong Jan 10, 2023 1:21pm

Karuna executive departs in lead up to pivotal drug launch

Jan 6, 2023 12:43pm

Safety data for Cerevel's schizophrenia drug de-risks asset

Dec 20, 2022 10:36am

Autoreceptor absence fuels dopamine dysfunction in schizophrenia

Nov 1, 2022 11:00am

Merck gains Moderna's cancer shot, signs Royalty collab

Oct 12, 2022 10:55am

Karuna hits goal in schizophrenia phase 3, teeing up 2023 filing

Aug 8, 2022 9:48am